🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
A prospective, randomized, placebo controlled, double-blinded study at a si...
Status
Terminated
Location
SJHMC/Barrow Neurosurgical Associates
Start Date
2015-03-01
Trial ID
NCT02276911
Treatments Being Tested
Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been found to have a...
Status
Unknown
Location
Fabrizio Cantini
Start Date
2015-01-01
Trial ID
NCT03244709
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
The purpose of the study is to investigate if intravenous fish oil, commerc...
Status
Terminated
Location
University of California, Los Angeles
Start Date
2009-08
Trial ID
NCT00969332
Treatments Being Tested
Comparison of the safety and effectiveness of standard drug dosing versus a...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00250432
Treatments Being Tested
This is a Phase 1, open-label, randomized, PK and safety study in a maximum...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2018-11-26
Trial ID
NCT03691584
Treatments Being Tested